{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T01:27:20Z","timestamp":1769909240911,"version":"3.49.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,2]],"date-time":"2021-11-02T00:00:00Z","timestamp":1635811200000},"content-version":"vor","delay-in-days":1,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006507","name":"Funda\u00e7\u00e3o Oswaldo Cruz","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006507","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004809","name":"Financiadora de Estudos e Projetos","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Brazilian Journal of Infectious Diseases"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.bjid.2021.101652","type":"journal-article","created":{"date-parts":[[2021,11,16]],"date-time":"2021-11-16T00:50:01Z","timestamp":1637023801000},"page":"101652","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Phase I safety and immunogenicity study of a Brazilian serogroup B vaccine"],"prefix":"10.1016","volume":"25","author":[{"given":"R. Menezes","family":"Martins","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5253-5774","authenticated-orcid":false,"given":"A.R.S.","family":"P\u00e9riss\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4656-1914","authenticated-orcid":false,"given":"L.A.B.","family":"Camacho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.L.","family":"Leal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.L.S.","family":"Maia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Homma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2865-8723","authenticated-orcid":false,"given":"E.","family":"Jessouroun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bjid.2021.101652_bib0001","series-title":"O Livro da Meningite","author":"Fonseca","year":"2004"},{"key":"10.1016\/j.bjid.2021.101652_bib0002","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1590\/S0102-311X2005000500019","article-title":"A doen\u00e7a meningoc\u00f3cica em S\u00e3o Paulo, Brasil, no s\u00e9culo XX: caracter\u00edsticas epidemiol\u00f3gicas","volume":"21","author":"Moraes","year":"2005","journal-title":"Cad Saude Publica"},{"key":"10.1016\/j.bjid.2021.101652_bib0003","series-title":"Imuniza\u00e7\u00f5es, 5th. ed","first-page":"387","article-title":"Vacinas meningoc\u00f3cicas","author":"S\u00e1fadi","year":"2008"},{"key":"10.1016\/j.bjid.2021.101652_bib0004","first-page":"82","article-title":"Bio-Manguinhos na origem: um cap\u00edtulo da hist\u00f3ria da auto-sufici\u00eancia tecnol\u00f3gica em sa\u00fade no Brasil","volume":"53","author":"Azevedo","year":"2007"},{"key":"10.1016\/j.bjid.2021.101652_bib0005","series-title":"Doen\u00e7a Meningoc\u00f3cica. Bol Epidemiol","year":"2019"},{"key":"10.1016\/j.bjid.2021.101652_bib0006","doi-asserted-by":"crossref","first-page":"e33016","DOI":"10.1371\/journal.pone.0033016","article-title":"Molecular Epidemiology of Neisseria meningitides Serogroup B in Brazil","volume":"7","author":"de Filippis","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.bjid.2021.101652_bib0007","unstructured":"SINAN, http:\/\/portalsinan.saude.gov.br\/meningite 2021"},{"key":"10.1016\/j.bjid.2021.101652_bib0008","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1128\/jcm.30.5.1282-1286.1992","article-title":"Emergence of a new clone of serogroup C Neisseria meningitides in S\u00e3o Paulo, Brazil","volume":"30","author":"Sacchi","year":"1992","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.bjid.2021.101652_bib0009","doi-asserted-by":"crossref","first-page":"4419","DOI":"10.1128\/iai.62.10.4419-4424.1994","article-title":"Immune response of Brazilian children to a Neisseria meningitides serogroup B outer membrane protein vaccine: comparison with Efficacy 1994","volume":"62","author":"Milagres","year":"1994","journal-title":"Intection Immunity"},{"key":"10.1016\/j.bjid.2021.101652_bib0010","doi-asserted-by":"crossref","first-page":"B26","DOI":"10.1016\/j.vaccine.2011.12.032","article-title":"The changing and dynamic epidemiology of meningococcal disease","volume":"30S","author":"Halperina","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.bjid.2021.101652_bib0011","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1179\/016164110X12644252260754","article-title":"Epidemiology of meningococcal disease in Latin America: current situation and opportunities for prevention","volume":"32","author":"S\u00e1fadi","year":"2010","journal-title":"Neurol Res"},{"key":"10.1016\/j.bjid.2021.101652_bib0012","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1080\/14760584.2017.1258308","article-title":"The Global Meningococcal Initiative: global epidemiology, the impact of vaccines on meningococcal disease and the importance of herd protection","volume":"16","author":"Borrow","year":"2017","journal-title":"Expert Review Vaccines"},{"key":"10.1016\/j.bjid.2021.101652_bib0013","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S2049-0801(13)70037-2","article-title":"Shea the long road to an effective vaccine for meningococcus group B (MenB)","volume":"2","author":"Michael","year":"2013","journal-title":"Annal Med Surg"},{"key":"10.1016\/j.bjid.2021.101652_bib0014","doi-asserted-by":"crossref","first-page":"174","DOI":"10.4161\/hv.18500","article-title":"Bexsero: a multicomponent vaccine for prevention of meningococcal disease","volume":"8","author":"Gorringe","year":"2012","journal-title":"Hum Vac Immunoth"},{"key":"10.1016\/j.bjid.2021.101652_bib0015","first-page":"E257","article-title":"A new meningococcal B vaccine for adolescents and adults: characteristics and methods of use","volume":"59","author":"Azzari","year":"2018","journal-title":"J. Prev. Med. Hyg"},{"key":"10.1016\/j.bjid.2021.101652_bib0016","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1128\/CVI.00230-06","article-title":"Immunogenicity and safety of three doses of a bivalent (B:4:P1.19,15 and B:4:P1.7-2,4) meningococcal outer membrane vesicle vaccine in healthy adolescents","volume":"14","author":"Boutriau","year":"2007","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.bjid.2021.101652_bib0017","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1093\/ije\/24.5.1050","article-title":"Assessment of the direct effectiveness of BC meningococcal vaccine in Rio de Janeiro, Brazil: a case-control study","volume":"24","author":"Noronha","year":"1995","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.bjid.2021.101652_bib0018","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1093\/aje\/kwm147","article-title":"A prospective study of the effectiveness of the New Zealand meningococcal B vaccine","volume":"166","author":"Kelly","year":"2007","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.bjid.2021.101652_bib0019","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1136\/adc.2007.132571","article-title":"Phase II meningococcal B vesicle vaccine trial in New Zealand infants","volume":"94","author":"Jackson","year":"2009","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.bjid.2021.101652_bib0020","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1016\/j.vaccine.2003.12.009","article-title":"Outer membrane vesicles (OMVs) and detoxified lipooligosaccharide (dLOS) obtained from Brazilian prevalent N. meningitidis serogroup B strains protect mice against homologous and heterologous meningococcal infection and septic shock","volume":"22","author":"Jessouroun","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.bjid.2021.101652_bib0021","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1126\/science.287.5459.1816","article-title":"Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing","volume":"287","author":"Pizza","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.bjid.2021.101652_bib0022","first-page":"170","article-title":"Recent advances in the large scale fermentation of Neisseria meningitidis group B for the production of an outer membrane protein complex","volume":"13","author":"Fu","year":"1995","journal-title":"Biotechnology"},{"key":"10.1016\/j.bjid.2021.101652_bib0023","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1084\/jem.129.6.1349","article-title":"Human immunity to the meningococcus. 3. Preparation and immunochemical properties of the group A, group B, and group C meningococcal polysaccharides","volume":"129","author":"Gotschlich","year":"1969","journal-title":"J Exp Med"},{"key":"10.1016\/j.bjid.2021.101652_bib0024","first-page":"970","article-title":"Interlaboratory standardization of the measurement of serum bactericidal activity by using human complement against meningococcal serogroup b, strain 44\/76-SL, before and after vaccination with the Norwegian MenBvac outer membrane vesicle vaccine","volume":"12","author":"Borrow","year":"2005","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.bjid.2021.101652_bib0025","doi-asserted-by":"crossref","first-page":"5093","DOI":"10.1016\/j.vaccine.2006.03.091","article-title":"Neisseria meningitidis group B correlates of protection and assay standardization\u2013international meeting report Emory University, Atlanta, Georgia, United States, 16-17 March 2005","volume":"24","author":"Borrow","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.bjid.2021.101652_bib0026","first-page":"255","article-title":"Determination of antibody responses to meningococcal antigens by ELISA","volume":"66","author":"Rosenqvist","year":"2001","journal-title":"Methods Mol Med"},{"key":"10.1016\/j.bjid.2021.101652_bib0027","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1128\/IAI.00882-06","article-title":"Affinity-purified human immunoglobulin G that binds a lacto-N-neotetraose-dependent lipooligosaccharide structure is bactericidal for serogroup B Neisseria meningitidis","volume":"75","author":"Estabrook","year":"2007","journal-title":"Infect Immun"},{"key":"10.1016\/j.bjid.2021.101652_bib0028","first-page":"373","article-title":"World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects","volume":"79","year":"2001","journal-title":"J Bull World Health Organ"},{"key":"10.1016\/j.bjid.2021.101652_bib0029","series-title":"2001\/20\/EC of the European Parliament and Concil","first-page":"34","year":"2001"},{"key":"10.1016\/j.bjid.2021.101652_bib0030","series-title":"Conselho Nacional de Sa\u00fade. RESOLU\u00c7\u00c3O N\u00b0 196, DE 10 DE OUTUBRO DE","year":"1996"},{"key":"10.1016\/j.bjid.2021.101652_bib0031","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1001\/jama.281.16.1520","article-title":"Immunogenicity of 2 serogroup outer-membrane protein meningococcal vaccines: a randomized controlled trial in Chile","volume":"281","author":"Tappero","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.bjid.2021.101652_bib0032","doi-asserted-by":"crossref","first-page":"3080","DOI":"10.1016\/j.vaccine.2007.01.022","article-title":"Safety review: two outer membrane vesicle (OMV) vaccines against systemic Neisseria meningitidis serogroup B disease","volume":"25","author":"Nokleby","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.bjid.2021.101652_bib0033","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1016\/j.vaccine.2005.09.043","article-title":"Safety and immunogenicity of New Zealand strain meningococcal serogroup B, OMV vaccine in healthy adults : Beginning of epidemic control","volume":"24","author":"Thornton","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.bjid.2021.101652_bib0034","first-page":"5093","volume":"24","year":"2006"},{"key":"10.1016\/j.bjid.2021.101652_bib0035","doi-asserted-by":"crossref","first-page":"4557","DOI":"10.1128\/IAI.00466-06","article-title":"Comparison and correlation of Neisseria meningitidis serogroup B immunologic assay results and human antibody responses following three doses of the Norwegian meningococcal outer membrane vesicle vaccine MenBVac","volume":"74","author":"Findlow","year":"2006","journal-title":"Infect Immun"},{"key":"10.1016\/j.bjid.2021.101652_bib0036","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1016\/j.vaccine.2005.01.051","article-title":"Meningococcal surrogates of protection - serum bactericidal antibody activity","volume":"23","author":"Borrow","year":"2005","journal-title":"Vaccine"}],"container-title":["The Brazilian Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1413867021001215?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1413867021001215?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T15:56:54Z","timestamp":1761407814000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1413867021001215"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":36,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["S1413867021001215"],"URL":"https:\/\/doi.org\/10.1016\/j.bjid.2021.101652","relation":{},"ISSN":["1413-8670"],"issn-type":[{"value":"1413-8670","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Phase I safety and immunogenicity study of a Brazilian serogroup B vaccine","name":"articletitle","label":"Article Title"},{"value":"The Brazilian Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bjid.2021.101652","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Sociedade Brasileira de Infectologia. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}],"article-number":"101652"}}